Safety Profile of the Pelabresib and Ruxolitinib Combination in Myelofibrosis

Opinion
Video

Panelists discuss the safety profile of the pelabresib and ruxolitinib combination in myelofibrosis.

Recent Videos
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content